{
  "denotations": [
    {
      "id": "T1",
      "obj": "Chemical",
      "span": {
        "begin": 0,
        "end": 12
      }
    },
    {
      "id": "T2",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 44,
        "end": 50
      }
    },
    {
      "id": "T4",
      "obj": "Chemical",
      "span": {
        "begin": 101,
        "end": 110
      }
    },
    {
      "id": "T5",
      "obj": "Chemical",
      "span": {
        "begin": 113,
        "end": 122
      }
    },
    {
      "id": "T6",
      "obj": "Chemical",
      "span": {
        "begin": 125,
        "end": 134
      }
    },
    {
      "id": "T7",
      "obj": "Chemical",
      "span": {
        "begin": 137,
        "end": 147
      }
    },
    {
      "id": "T8",
      "obj": "Chemical",
      "span": {
        "begin": 150,
        "end": 161
      }
    },
    {
      "id": "T9",
      "obj": "Chemical",
      "span": {
        "begin": 166,
        "end": 175
      }
    },
    {
      "id": "T10",
      "obj": "Chemical",
      "span": {
        "begin": 186,
        "end": 196
      }
    },
    {
      "id": "T16",
      "obj": "Chemical",
      "span": {
        "begin": 30,
        "end": 50
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "22348413_9",
  "text": "Itraconazole and other potent inhibitors of CYP3A4 could drastically increase exposure to drugs like midazolam , triazolam , buspirone , lovastatin , simvastatin and oxycodone , whereas rifampicin greatly reduced their plasma concentrations ."
}
